Document is current
Any future updates will be listed below
-
Authors
Kaier, Klaus
Heister, Thomas
Wolff, Jan
Wolkewitz, Martin
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative Joint Undertaking (115523 | 115620 | 115737)
Innovative Medicines Initiative Joint Undertaking (115737-2)
Deutsche Forschungsgemeinschaft (KA 4199/1-1, WO 1746/1-2)
- License Information
-
More Information
Article History
Received: 27 May 2019
Accepted: 20 March 2020
First Online: 31 March 2020
Ethics approval and consent to participate
: Patients provided informed written consent on admission to the use of their pseudonymized data for scientific purposes, in accordance with German data protection law. The use of the data was approved by the University Medical Center Freiburg Ethics Committee.The study design complies with institutional and national research ethics regulations and has been performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.
: Not applicable. The study only included pseudonymized routine data and the researchers were unable to connect data to individual patients.
: The authors declare that they have no competing interests.
